Gretchen Poortinga

3.6k total citations
31 papers, 2.0k citations indexed

About

Gretchen Poortinga is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Gretchen Poortinga has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Gretchen Poortinga's work include Genomics and Chromatin Dynamics (10 papers), RNA modifications and cancer (8 papers) and Ubiquitin and proteasome pathways (7 papers). Gretchen Poortinga is often cited by papers focused on Genomics and Chromatin Dynamics (10 papers), RNA modifications and cancer (8 papers) and Ubiquitin and proteasome pathways (7 papers). Gretchen Poortinga collaborates with scholars based in Australia, United States and Canada. Gretchen Poortinga's co-authors include Ross D. Hannan, Grant A. McArthur, Richard B. Pearson, Katherine M. Hannan, Susan M. Parkhurst, Kerith Sharkey, Meaghan Wall, Elaine Sanij, Tom Moss and Yves Brandenburger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Gretchen Poortinga

30 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gretchen Poortinga 1.7k 336 149 149 144 31 2.0k
Shin‐ichiro Kanno 1.4k 0.8× 333 1.0× 194 1.3× 224 1.5× 118 0.8× 32 1.6k
Yuzuru Shiio 1.5k 0.9× 364 1.1× 161 1.1× 292 2.0× 154 1.1× 34 1.9k
Craig R. Stumpf 1.7k 1.0× 210 0.6× 124 0.8× 196 1.3× 157 1.1× 23 2.0k
Caroline Schild‐Poulter 1.1k 0.6× 292 0.9× 161 1.1× 127 0.9× 124 0.9× 43 1.3k
Rosa Luna 1.7k 1.0× 360 1.1× 150 1.0× 213 1.4× 169 1.2× 40 2.0k
Katayoon H. Emami 1.2k 0.7× 331 1.0× 131 0.9× 119 0.8× 118 0.8× 10 1.4k
Sergei Chuikov 2.3k 1.3× 408 1.2× 212 1.4× 176 1.2× 105 0.7× 15 2.6k
Marie‐Luce Vignais 1.7k 1.0× 392 1.2× 130 0.9× 279 1.9× 246 1.7× 36 2.2k
Stephanie M. Bartley 1.5k 0.8× 464 1.4× 201 1.3× 223 1.5× 129 0.9× 15 1.8k
Bob D. Brown 1.1k 0.6× 321 1.0× 145 1.0× 160 1.1× 196 1.4× 32 1.5k

Countries citing papers authored by Gretchen Poortinga

Since Specialization
Citations

This map shows the geographic impact of Gretchen Poortinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gretchen Poortinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gretchen Poortinga more than expected).

Fields of papers citing papers by Gretchen Poortinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gretchen Poortinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gretchen Poortinga. The network helps show where Gretchen Poortinga may publish in the future.

Co-authorship network of co-authors of Gretchen Poortinga

This figure shows the co-authorship network connecting the top 25 collaborators of Gretchen Poortinga. A scholar is included among the top collaborators of Gretchen Poortinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gretchen Poortinga. Gretchen Poortinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cameron, Donald P., Denis Drygin, Gretchen Poortinga, et al.. (2024). CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci. Biomedicines. 12(7). 1514–1514. 4 indexed citations
2.
Maclachlan, Kylee, Jian Kang, Andrew Cuddihy, et al.. (2024). Targeting the ribosome to treat multiple myeloma. SHILAP Revista de lepidopterología. 32(1). 200771–200771. 6 indexed citations
3.
Kusnadi, Eric, Anna Trigos, Carleen Cullinane, et al.. (2020). Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis. The EMBO Journal. 39(21). e105111–e105111. 28 indexed citations
4.
Son, Jinbae, Katherine M. Hannan, Gretchen Poortinga, et al.. (2020). rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461. Frontiers in Cell and Developmental Biology. 8. 568–568. 17 indexed citations
5.
Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2019). First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer Discovery. 9(8). 1036–1049. 132 indexed citations
6.
Diesch, Jeannine, Megan J. Bywater, Elaine Sanij, et al.. (2019). Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation. Communications Biology. 2(1). 39–39. 32 indexed citations
7.
Maclachlan, Kylee, Andrew Cuddihy, Nadine Hein, et al.. (2017). Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma. Blood. 130. 1805. 3 indexed citations
8.
Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2017). RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study. Blood. 130. 3835–3835. 2 indexed citations
9.
Quin, Jaclyn, Keefe T. Chan, Jennifer R. Devlin, et al.. (2016). Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling. Oncotarget. 7(31). 49800–49818. 79 indexed citations
10.
Devlin, Jennifer R., Katherine M. Hannan, Nadine Hein, et al.. (2015). Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma. Cancer Discovery. 6(1). 59–70. 91 indexed citations
11.
Parsons, Linda M., et al.. (2015). Defective Hfp-dependent transcriptional repression of dMYC is fundamental to tissue overgrowth in Drosophila XPB models. Nature Communications. 6(1). 7404–7404. 10 indexed citations
12.
Lin, Jane I., Linda M. Parsons, Katarzyna Jastrzebski, et al.. (2015). S6 Kinase is essential for MYC-dependent rDNA transcription in Drosophila. Cellular Signalling. 27(10). 2045–2053. 14 indexed citations
13.
Sanij, Elaine, Jeannine Diesch, Gretchen Poortinga, et al.. (2014). A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes. Genome Research. 25(2). 201–212. 45 indexed citations
14.
Wall, Meaghan, Gretchen Poortinga, Kym L. Stanley, et al.. (2012). The mTORC1 Inhibitor Everolimus Prevents and Treats Eμ- Myc Lymphoma by Restoring Oncogene-Induced Senescence. Cancer Discovery. 3(1). 82–95. 52 indexed citations
15.
Poortinga, Gretchen, Meaghan Wall, Elaine Sanij, et al.. (2010). c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation. Nucleic Acids Research. 39(8). 3267–3281. 76 indexed citations
16.
Poortinga, Gretchen, Katherine M. Hannan, Carl R. Walkley, et al.. (2004). MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation. The EMBO Journal. 23(16). 3325–3335. 147 indexed citations
17.
Poortinga, Gretchen, et al.. (1998). Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and Hairy-mediated transcriptional repression. The EMBO Journal. 17(7). 2067–2078. 209 indexed citations
18.
Alifragis, Pavlos, Gretchen Poortinga, Susan M. Parkhurst, & Christos Delidakis. (1997). A network of interacting transcriptional regulators involved in Drosophila neural fate specification revealed by the yeast two-hybrid system. Proceedings of the National Academy of Sciences. 94(24). 13099–13104. 69 indexed citations
19.
Loughney, Kate, et al.. (1993). Characterization of Sequences Responsible for trans-Inactivation of the Drosophila brown Gene. Cold Spring Harbor Symposia on Quantitative Biology. 58(0). 577–584. 5 indexed citations
20.
Dutcher, Susan K., et al.. (1992). Tryptophan analog resistance mutations in Chlamydomonas reinhardtii.. Genetics. 131(3). 593–607. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin‐ichiro Kanno Breakdown of academic impact, for papers by Yuzuru Shiio Breakdown of academic impact, for papers by Craig R. Stumpf Breakdown of academic impact, for papers by Caroline Schild‐Poulter Breakdown of academic impact, for papers by Rosa Luna Breakdown of academic impact, for papers by Katayoon H. Emami Breakdown of academic impact, for papers by Sergei Chuikov Breakdown of academic impact, for papers by Marie‐Luce Vignais Breakdown of academic impact, for papers by Stephanie M. Bartley Breakdown of academic impact, for papers by Bob D. Brown
Rankless by CCL
2026